COIOSDeep risk insights through multi-disciplinary research across the globe
Rural village scene with houses and hedges
Item new Peer-reviewed Added

Blood-based multicancer screening did not reduce late-stage cancer in 142,250 adults

In the NHS-Galleri trial of 142,250 adults in England, three annual rounds of multicancer early-detection testing did not reduce stage III or IV cancer incidence (rate ratio 1.03).

The NHS-Galleri trial randomised 142,250 adults aged 50 to 77 in England to multicancer blood testing or usual care over three annual rounds. Incidence of stage III or IV cancer across 12 prespecified cancers did not differ between the groups, with a rate ratio of 1.03. For stage IV cancer alone, a secondary end point, the rate ratio was 0.86, with the confidence interval reaching 1.00.

Why it is interesting: A randomised trial of whether earlier detection shifts stage at diagnosis, rather than test accuracy.

Source
New England Journal of Medicine, 22 September 2026
Paper
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Authors
Sasieni P, Johnson P, Round T, Warwick J, Jones H, Dolly S et al.
DOI
10.1056/nejmoa2505723
Type
Peer-reviewed article
Design
Randomised controlled trial, 142,250 adults aged 50-77 in England, three annual screening rounds plus at least 12 months' follow-up
Verdict
New finding
Driver
Cancer
Free full text
Free copy in a repository (published version)
Attention
15 citations (Crossref) · as of 2026-11-19

Other drivers in Health today